Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery David Palma, Otto.

Slides:

Advertisements

Similar presentations

Detection of Abdominal Aortic Aneurysm in Patients with Peripheral Artery Disease A. Barba, L. Estallo, L. Rodríguez, M. Baquer, M. Vega de Céniga European.

Advertisements

The most efficient STR loci in forensic genetics in population of central Poland R. Jacewicz, M. Jedrzejczyk, J. Berent Forensic Science International:

The Survival Kit: Software to analyze survival data including possibly correlated random effects G. Mészáros, J. Sölkner, V. Ducrocq Computer Methods and.

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer Julie Leseur, Geoffrey Roman-Jimenez, Anne Devillers,

Su K. Metcalfe, MD, MPH, Michael T

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer

Philipp Dahm, Ari D. Silverstein, Alon Z

Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: Are they just apples and oranges? C.-T. Chiu,

Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results.

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without.

Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases Gerhard Lonnemann, Johannes Duttlinger,

Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan? Liesbeth J. Boersma, Bianca Hanbeukers, Carla Boetes,

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – The ARTSCAN.

The dose–response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysis Christopher R. King Radiotherapy and.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Trine Grantzau, Mette Skovhus Thomsen, Michael Væth, Jens Overgaard

Critical Reviews in Oncology / Hematology

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Pain in cancer survivors; filling in the gaps

Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Cornelis J. A. Haasbeek, MD, PhD, Frank J. Lagerwaard, MD, PhD, Ben J

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

Casimir A. E. Kouwenberg, Leonieke W. Kranenburg, Martijn S

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer Masatsugu Hamaji,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Joshua E. Rosen, BASc, Michelle C

Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer Frank J. Lagerwaard, MD, PhD, Neil K. Aaronson,

Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer Max Dahele, MBChB, MSc, David Palma, MD, Frank Lagerwaard, MD, PhD, Ben Slotman,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Volume 385, Issue 9962, Pages (January 2015)

Changing demographics in patients with vascular disease

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer Eric D. Miller, MD,

Volume 19, Issue 4, Pages (September 2012)

Vincent L. Rowe, MD, William Lee, MD, Fred A

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer Eva M. Bongers, MD, Cornelis.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy Naomi E. Verstegen,

David A. Clark, Upender K. Munshi Pathophysiology

Long-term follow-up of mitral valve regurgitation��Importance of mitral valve pathology and left ventricular function on survival Krister Lindmark,

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Skin cancer epidemic in a wireless world

Increasing incidence of brain tumours in sparsely populated areas

The “obesity paradox” in an elderly population with a high prevalence of Chagas disease: The 10-year follow-up of the Bambuí (Brazil) Cohort Study of.

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Journal of Thoracic Oncology

Liseth L. van den Berg, MD, Theo J. Klinkenberg, MD, Harry J. M

Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013 Chris Dickhoff, MD, Max Dahele, MBChB., PhD,

Presentation transcript:

Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery David Palma, Otto Visser, Frank J. Lagerwaard, Jose Belderbos, Ben Slotman, Suresh Senan Radiotherapy and Oncology Volume 101, Issue 2, Pages 240-244 (November 2011) DOI: 10.1016/j.radonc.2011.06.029 Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Overall survival (OS) for 120 elderly patients (age ⩾75) with stage I NSCLC by treatment. There was no difference in OS between surgery and SBRT (log-rank test p=0.22). Radiotherapy and Oncology 2011 101, 240-244DOI: (10.1016/j.radonc.2011.06.029) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Overall survival (OS) for the subset of elderly SBRT patients (age ⩾75) with pathological confirmation of disease versus the corresponding matched patients who underwent surgery. There was no difference in OS between surgery and SBRT (log-rank test p=0.36). Radiotherapy and Oncology 2011 101, 240-244DOI: (10.1016/j.radonc.2011.06.029) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions